A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity

Eur J Med Chem. 2022 Jan 15:228:113983. doi: 10.1016/j.ejmech.2021.113983. Epub 2021 Nov 19.

Abstract

Following our study of 4'-truncated (N)-methanocarba-adenosine derivatives that displayed unusually high mouse (m) A3AR affinity, we incorporated dopamine-related N6 substituents in the full agonist 5'-methylamide series. N6-(2-(4-Hydroxy-3-methoxy-phenyl)ethyl) derivative MRS7618 11 displayed Ki (nM) 0.563 at hA3AR (∼20,000-fold selective) and 1.54 at mA3AR. 2-Alkyl ethers maintained A3 affinity, but with less selectivity than 2-alkynes. Parallel functional assays of G protein-dependent and β-arrestin 2 (βarr2)-dependent pathways indicate these are full agonists but not biased. Through use of computational modeling, we hypothesized that phenyl OH/OMe groups interact with polar residues, particularly Gln261, on the mA3AR extracellular loops as the basis for the affinity enhancement. Although the pharmacokinetics indicated facile clearance of parent O-methyl catechol nucleosides 21 and 31, prolonged mA3AR activation in vivo was observed in a hypothermia model, suggested potential formation of active metabolites through demethylation. Selected analogues induced mouse hypothermia following i.p. injection, indicative of peripheral A3AR agonism in vivo.

Keywords: Adenosine receptor; G protein-coupled receptor; Hypothermia; Molecular modeling; Nucleosides; Structure activity relationship.

MeSH terms

  • Adenosine A3 Receptor Agonists / chemical synthesis
  • Adenosine A3 Receptor Agonists / chemistry
  • Adenosine A3 Receptor Agonists / pharmacology*
  • Dopamine / chemical synthesis
  • Dopamine / chemistry
  • Dopamine / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Structure
  • Receptor, Adenosine A3 / metabolism*
  • Structure-Activity Relationship

Substances

  • Adenosine A3 Receptor Agonists
  • Receptor, Adenosine A3
  • Dopamine